"High cholesterol levels may impair fertility in couples trying to achieve a pregnancy, according to a study by researchers at the National Institutes of Health, the University at Buffalo (New York), and Emory University in Atlanta.
(Generic versions may still be available.)
FertinexTM (urofollitropin for injection, purified) is contraindicated in women who exhibit :
1. High levels of FSH indicating primary ovarian failure.
4. The presence of any cause of infertility other than anovulation, as stated in the "Indications" unless they are candidates for Assisted Reproductive Technologies.
6. Ovarian cysts or enlargement of undetermined origin.
7. Prior hypersensitivity to urofollitropin.
Fertinex (urofollitropin) TM is also contraindicated in women who are pregnant and may cause fetal harm when administered to a pregnant woman. There are limited human data on the effects of Fertinex (urofollitropin) TM when administered during pregnancy.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Fertinex Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Trying to Conceive
Get tips and advances in treatment.